Parallel derivation of isogenic human primed and naive induced pluripotent stem cells

平行诱导同源人类启动和未启动诱导多能干细胞

阅读:4
作者:Stéphanie Kilens ,Dimitri Meistermann ,Diego Moreno ,Caroline Chariau ,Anne Gaignerie ,Arnaud Reignier ,Yohann Lelièvre ,Miguel Casanova ,Céline Vallot ,Steven Nedellec ,Léa Flippe ,Julie Firmin ,Juan Song ,Eric Charpentier ,Jenna Lammers ,Audrey Donnart ,Nadège Marec ,Wallid Deb ,Audrey Bihouée ,Cédric Le Caignec ,Claire Pecqueur ,Richard Redon ,Paul Barrière ,Jérémie Bourdon ,Vincent Pasque ,Magali Soumillon ,Tarjei S Mikkelsen ,Claire Rougeulle ,Thomas Fréour ,Laurent David

Abstract

Induced pluripotent stem cells (iPSCs) have considerably impacted human developmental biology and regenerative medicine, notably because they circumvent the use of cells of embryonic origin and offer the potential to generate patient-specific pluripotent stem cells. However, conventional reprogramming protocols produce developmentally advanced, or primed, human iPSCs (hiPSCs), restricting their use to post-implantation human development modeling. Hence, there is a need for hiPSCs resembling preimplantation naive epiblast. Here, we develop a method to generate naive hiPSCs directly from somatic cells, using OKMS overexpression and specific culture conditions, further enabling parallel generation of their isogenic primed counterparts. We benchmark naive hiPSCs against human preimplantation epiblast and reveal remarkable concordance in their transcriptome, dependency on mitochondrial respiration and X-chromosome status. Collectively, our results are essential for the understanding of pluripotency regulation throughout preimplantation development and generate new opportunities for disease modeling and regenerative medicine.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。